Marco Rosati

Marco Rosati is a board-certified veterinary pathologist (DACVP) with a Doctor of Veterinary Medicine and a PhD. They completed their veterinary education at the University of Bologna, graduating with honors in 2007. Marco has held significant positions in academia and industry, including a role as Associate Director of Pathology at AstraZeneca, where they focus on pioneering AI-driven biomarker discovery in oncology research and development. Previously, they have contributed to veterinary neuropathology and critical care at Ludwig-Maximilians-Universität München and the University of Bologna.